GKB Ophthalmics Limited shareholders have passed resolutions through postal ballot on November 1, 2025, approving the voluntary winding up of material subsidiary GSV Ophthalmics Private Limited and related party transactions worth Rs. 15.00 crores.

GKB Ophthalmics Ltd. sought shareholder approval for two key resolutions through a remote e-voting process, which concluded on November 1, 2025.

Voting Results

The voting results, as reported by the scrutinizer, Shivaram Bhat, show mixed outcomes for the two resolutions:

Key Points

1. Voting Process: The e-voting period ran from October 3, 2025, to November 1, 2025, with 2,658 shareholders eligible to vote as of the record date (September 26, 2025).

2. Shareholder Correction: One shareholder holding 134,218 shares requested a correction of their vote on Resolution 1 from dissent to assent, citing an inadvertent error. The company accommodated this request, considering these votes in favor of the resolution.

3. Resolution Outcomes:

   • The first resolution, seeking approval for the Related Party Transaction related to winding up, did not pass despite the vote correction.
   • The second resolution for the voluntary winding up of GSV Ophthalmics Private Limited passed with an overwhelming majority.

4. Regulatory Compliance: The company conducted the postal ballot in accordance with Section 110 of the Companies Act, 2013, and SEBI regulations.

Implications

The approval of the voluntary winding up of GSV Ophthalmics Private Limited indicates shareholder support for this decision. The subsidiary, which holds the company's Rs. 11.70 crores investment, never commenced operations since inception due to COVID-19 disruptions, making the project financially unviable.

Despite the approval for winding up, the rejection of the first resolution suggests potential complications in executing this decision, as it relates to the approval of related party transactions necessary for the winding-up process.

GKB Ophthalmics' management may need to reassess their approach to the winding-up process in light of these voting results. The company might consider engaging with shareholders to address concerns related to the related party transaction aspects of the winding-up procedure.

The proceeds from the winding up are expected to be used for general corporate purposes.

As this corporate action unfolds, stakeholders will be watching closely to see how GKB Ophthalmics navigates the path forward for its material subsidiary, GSV Ophthalmics Private Limited, in light of these shareholder decisions.

GKB Ophthalmics , a leading manufacturer of ophthalmic lenses, has announced significant operational changes at its Goa plant due to market challenges, while simultaneously receiving recognition for its export performance.

Production Cutback and Workforce Reduction

GKB Ophthalmics has implemented a 50% reduction in production at its plant located in Tivim Industrial Estate, Mapusa, Goa. The company attributes this decision to two primary factors:

1. Sluggish market demand
2. Complete cessation of export orders from its US subsidiary

The company cited heavy tariff impositions as the reason for the halt in US export orders. In response to these challenges, GKB Ophthalmics is also taking steps to optimize its workforce:

• Gradually releasing temporary workers
• Aiming to reduce labor costs

Export Excellence Recognition

Despite the current market headwinds, GKB Ophthalmics has received notable recognition for its past export performance. The Plastic Export Promotion Council, under the Department of Commerce, Government of India, has selected the company for an Export Excellence Award in the "Hard Resilent Lenses" category.

This award acknowledges GKB Ophthalmics' exceptional export performance, highlighting the company's strong presence in international markets prior to the recent challenges.

Looking Ahead

GKB Ophthalmics has stated that it will continue to monitor the situation in the coming months and adjust its business operations accordingly. The company's ability to navigate these challenges while maintaining its export quality will be crucial for its future performance.

As global market dynamics continue to evolve, particularly with respect to international trade policies and tariffs, companies like GKB Ophthalmics will need to demonstrate agility in their operational strategies to maintain their competitive edge in the ophthalmic lens industry.